NEJM Interviews

NEJM Group
  • 0.0 (0)
  • MEDICINA
  • CADA DOS SEMANAS

Insightful conversations with leading experts in the field of health care, medical research, policy, and more from the New England Journal of Medicine (NEJM). Each episode examines the many complexities found at the junction of medicine and society.

  1. HACE 21 H

    NEJM Interview: Rachel Sachs on recent agreements governing coverage and pricing of GLP-1 receptor agonists in the United States.

    Rachel Sachs is a professor of law at Washington University in St. Louis. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. S.B. Dusetzina and R.E. Sachs. Insurance Coverage and Pricing of Weight-Loss Drugs in the United States. N Engl J Med 2026;394:105-107. S. Gondi, A.S. Kesselheim, and B.N. Rome. Generic Liraglutide — Overlooked but Not Forgotten. N Engl J Med. DOI: 10.1056/NEJMp2515668.

    11 min

  2. 31/12/2025

    NEJM Interview: Ambar La Forgia on the drivers and effects of corporatization of outpatient medical services.

    Ambar La Forgia is an assistant professor in the Management of Organizations group at the University of California, Berkeley Haas School of Business. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A. La Forgia. From Patients to Consumers — The Corporatization of Ambulatory Care. N Engl J Med 2026;394:1-3.

    10 min

  3. 17/12/2025

    NEJM Interview: Anne Zink on increases in rates of congenital syphilis and potential strategies for reversing this trend.

    Anne Zink is a lecturer and senior fellow at the Yale School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A.B. Zink, N.C. McCann, and R.P. Walensky. From Crisis to Action — Policy Pathways to Reverse the Rise in Congenital Syphilis. N Engl J Med 2025;393:2388-2391.

    8 min

  4. 10/12/2025

    NEJM Interview: Reshma Ramachandran on changes to the FDA’s adverse-event data releases and future directions for enhancing its safety-surveillance infrastructure.

    Reshma Ramachandran is an assistant professor of medicine at the Yale School of Medicine. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J.D. Wallach, J.S. Ross, and R. Ramachandran. Enhancing FDA Drug-Safety Surveillance — Beyond Releasing Daily Adverse-Event Data. N Engl J Med 2025;393:2284-2286.

    10 min

  5. 03/12/2025

    NEJM Interview: Robert Huckman on the dearth of successful business models aimed at keeping people healthy.

    Robert Huckman is a professor of business administration at Harvard Business School and a research associate at the National Bureau of Economic Research. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. D.M. Cutler and R.S. Huckman. Has Corporatization Met Its Match? The Challenge of Making Money by Keeping People Healthy. N Engl J Med 2025;393:2177-2180.

    15 min

  6. 26/11/2025

    NEJM Interview: Nishant Uppal on the emergence of venture capital investing by academic medical centers and its potential implications.

    Nishant Uppal is an instructor in medicine at Massachusetts General Hospital. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. N. Uppal and Z. Song. Venture Capital Investments by U.S. Academic Medical Centers. N Engl J Med 2025;393:2077-2080.

    12 min

  7. 19/11/2025

    NEJM Interview: Jane Zhu on a new Oregon law that aims to address corporate control in medicine.

    Jane Zhu is an associate professor of medicine in the Division of General Internal Medicine at Oregon Health and Science University. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J.M. Zhu and H. Rooke-Ley. Regulating Corporate Control in Health Care — Oregon’s Attempt to Revive the CPOM Doctrine. N Engl J Med 2025;393:1972-1974.

    11 min

  8. 12/11/2025

    NEJM Interview: Joshua Barocas on recent federal actions related to harm-reduction programs for people with substance use disorders.

    Joshua Barocas is an associate professor of medicine at the University of Colorado Anschutz Medical Campus. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J.A. Barocas. The Erosion of Harm Reduction. N Engl J Med 2025;393:1865-1867. B.A. Barsky, A. Caplan-Bricker, and C. Robertson. Religious Liberty as a Shield for Public Health — The Case of Overdose-Prevention Centers. N Engl J Med 2025;393:1867-1869.

    13 min
Ver todo (919)

Acerca de

Insightful conversations with leading experts in the field of health care, medical research, policy, and more from the New England Journal of Medicine (NEJM). Each episode examines the many complexities found at the junction of medicine and society.

Información

  • Canal
    NEJM Group
  • Creador
    NEJM Group
  • Años de actividad
    2006 - 2026
  • Episodios
    919
  • Clasificación
    Apto
  • Copyright
    © Copyright 2026 Massachusetts Medical Society
  • Mostrar sitio web
    NEJM Interviews

Más de NEJM Group

También te podría interesar